BridgeMD
New treatment option for Communication Research
Official title STOP? II: Testing of a Toolbox for Structured Communication in the Operating Room
ClinicalTrials.gov ID: NCT05356962
What this study is testing
- What it's testing
- The purpose of the study is to test the impact of the StOP?-protocol - an intra-operative communication briefing, on post-operative mortality and important patient outcomes.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- For the clusters (surgeons)
- Board-certified surgeons with specialization in one of the following disciplines: general, visceral, thoracic, vascular surgery, surgical urology, or...
You likely can't join if
- Surgeons who are already performing StOP?-protocol. (Potentially, surgeons who took part in the first study (StOP-I) may still perform StOP?).
- Surgeon who were previously enrolled in the StOP?-II trial (this is relevant for surgeons who move or rotate between departments/hospitals and might...
- Patients operated by cluster surgeons during the cluster-specific time period
- General consent from the patients, allowing the use of healthcare-related data that are the result of the patient's treatment. In case no written...
- Patient age below 18 years
- Previous operation at the same site up to 30 days prior the index operation
See the full eligibility criteria
- For the clusters (surgeons)
- Board-certified surgeons with specialization in one of the following disciplines: general, visceral, thoracic, vascular surgery, surgical urology, or gynecology.
- Surgeons who are already performing StOP?-protocol. (Potentially, surgeons who took part in the first study (StOP-I) may still perform StOP?).
- Surgeon who were previously enrolled in the StOP?-II trial (this is relevant for surgeons who move or rotate between departments/hospitals and might therefore be working at different participating sites). For the...
- Patients operated by cluster surgeons during the cluster-specific time period
- General consent from the patients, allowing the use of healthcare-related data that are the result of the patient's treatment. In case no written document from the general consent is available despite documented efforts...
- Patient age below 18 years
- Previous operation at the same site up to 30 days prior the index operation
- Procedures not done in operating rooms but in outpatient clinics, on wards, etc.
- Mainly diagnostic endoscopic procedures (e.g. colonoscopy, gastroscopy, bronchoscopy)
- Percutaneous interventions (e.g., transurethral interventions)
- Documented refusal for the use of healthcare related data
The study team makes the final eligibility decision.
Where it's taking place
- Innsbruck, Austria
- Liestal, Basel-Landschaft, Switzerland
- Baden, Canton of Aargau, Switzerland
- Bern, Canton of Bern, Switzerland
- Fribourg, Canton of Fribourg, Switzerland
- Lausanne, Canton of Vaud, Switzerland
- Schlieren, Canton of Zurich, Switzerland
- Winterthur, Canton of Zurich, Switzerland
- Zurich, Canton of Zurich, Switzerland
- Lugano, Canton Ticino, Switzerland
- Chur, Kanton Graubünden, Switzerland
- Frauenfeld, Thurgau, Switzerland
- Neuchâtel, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Innsbruck, Austria; Liestal, Basel-Landschaft, Switzerland; Baden, Canton of Aargau, Switzerland; Bern, Canton of Bern, Switzerland; Fribourg, Canton of Fribourg, Switzerland; Lausanne, Canton of Vaud, Switzerland and 7 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.